Infectious diseases, especially those affecting people who are immunocompromised, require intensive, sophisticated approaches to prevention and treatment. The Icahn School of Medicine at Mount Sinai’s history of leadership in infectious disease management, its diverse patient population, and its pioneering faculty in research have positioned the institution as a leader in the New York tri-state region and across the country.

Located on the border of East Harlem, with its predominantly poor and largely immigrant population, and the Upper East Side of Manhattan, one of the wealthiest neighborhoods in the nation, The Mount Sinai Hospital attracts an ethnically diverse patient population whose actions and travel habits frequently lead to exposure to both common and unusual infectious diseases. Since the integration of the Mount Sinai Health System, we provide care to patients throughout New York City, Long Island and New Jersey.

Icahn Mount Sinai faculty and trainees also care for patients at NYC Health + Hospitals/Elmhurst Hospital Center in Queens. Located in the most ethnically diverse square mile in the world, our physicians treat conditions that are extremely rare and even unheard of in other parts of the country. This rich diversity translates into benefits for everyone. Our physicians hone their skills working on some of the most challenging cases ever seen in the area, making them among the best clinicians anywhere.

In addition, we provide care and conduct research at the James J. Peters Department of Veterans Affairs Medical Center. We are proud to be affiliated with the Veterans Health Administration serving those who have served for our country. The Veterans Affairs Office of Research and Development offers unique opportunities to fund basic, translational, and clinical research. The Veterans Affairs registry is among the largest health databases that can be accessed for quality improvements such as safety, efficacy, and best practices as well as providing data that can be used for supporting translational and interventional research.

Our investigations focus on improving patient outcomes and rapidly translating our findings into patient care. Our trainees have learning opportunities that would be difficult to find anywhere else in the United States. Most importantly, our patients benefit from the talent and experience of our clinicians and researchers, and often have access to experimental treatments before they are widely available.

As we look to the future, the Division of Infectious Diseases remains committed to pushing the boundaries of medical science and providing exceptional care to our diverse patient population. Through our continued dedication to research, education, and clinical excellence, we strive to meet the evolving challenges of infectious diseases and improve global health outcomes.

Judith Aberg, MD, FIDA, FACP
Dr. George Baehr Professor of Clinical Medicine
Chief, Division of Infectious Diseases
Dean, System Operations for Clinical Sciences